Prescription Technology Solutions — Total other segment expense, net
McKesson Prescription Technology Solutions — Total other segment expense, net decreased by 2.4% to $1.21B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.8%, from $1.09B to $1.21B. Over 3 years (FY 2023 to FY 2026), Prescription Technology Solutions — Total other segment expense, net shows an upward trend with a 7.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase relative to revenue may signal declining operational efficiency or rising overhead costs.
Detailed definition
This metric reflects the net total of miscellaneous expenses incurred by the Prescription Technology Solutions segment t...
Peer comparison
Comparable to 'unallocated corporate expenses' or 'other segment operating costs' at peer companies.
mck_segment_prescription_technology_solutions_total_other_segment_expense_netHistorical Data
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $955.25M | $955.25M | $955.25M | $955.25M | $983.5M | $983.5M | $983.5M | $983.5M | $1.04B | $1.06B | $1.15B | $1.09B | $1.18B | $1.13B | $1.24B | $1.21B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +3.0% | +0.0% | +0.0% | +0.0% | +5.5% | +2.1% | +8.7% | -5.3% | +8.2% | -4.1% | +9.5% | -2.4% |
| YoY Change | — | — | — | — | +3.0% | +3.0% | +3.0% | +3.0% | +5.5% | +7.8% | +17.1% | +10.9% | +13.8% | +6.8% | +7.6% | +10.8% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's prescription technology solutions — total other segment expense, net?
- McKesson (MCK) reported prescription technology solutions — total other segment expense, net of $1.21B in Q1 2026.
- How has McKesson's prescription technology solutions — total other segment expense, net changed year-over-year?
- McKesson's prescription technology solutions — total other segment expense, net increased by 10.8% year-over-year, from $1.09B to $1.21B.
- What is the long-term trend for McKesson's prescription technology solutions — total other segment expense, net?
- Over 3 years (2023 to 2026), McKesson's prescription technology solutions — total other segment expense, net has grown at a 7.6% compound annual growth rate (CAGR), from $3.82B to $4.76B.
- What does prescription technology solutions — total other segment expense, net mean?
- The net total of indirect or miscellaneous expenses for the technology solutions segment.